Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes
Open Access
- 26 March 2014
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 24 (9) , 1442-1446
Abstract
In severely obese type 2 diabetes patients, gastric bypass surgery (GB) reduces body mass index (BMI) and hemoglobin A1c (HbA1c) and allows reduced doses of insulin and other medications. Data regarding the effects of GB on severely obese patients with type 1 diabetes are limited.Keywords
This publication has 19 references indexed in Scilit:
- Insulin Sensitivity and Secretion Changes After Gastric Bypass in Normotolerant and Diabetic Obese SubjectsAnnals of Surgery, 2013
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesNew England Journal of Medicine, 2012
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 DiabetesNew England Journal of Medicine, 2012
- Adjunct therapy for type 1 diabetes mellitusNature Reviews Endocrinology, 2010
- Temporal patterns in overweight and obesity in Type 1 diabetesDiabetic Medicine, 2010
- Endocrine and metabolic response to gastric bypassCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysisThe American Journal of Medicine, 2009
- Long-Term Mortality after Gastric Bypass SurgeryNew England Journal of Medicine, 2007
- Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric SurgeryNew England Journal of Medicine, 2004
- Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes MellitusAnnals of Surgery, 2003